Orofacial Pain: A Guide to Medications and Management brings together guidance and information on the rational use of medications for the treatment of chronic orofacial pain. Focusing on clinically relevant information throughout and aiming itself squarely at the needs of dentists and other clinicians working directly with orofacial pain, the book covers the use of oral, injectable and topical medications for managing neuropathic and musculoskeletal pain, headache, and uncommon orofacial pain disorders. Useful features, such as discussion of the top 60 medications prescribed for orofacial pain, are integrated with comprehensive coverage of drug types, pharmacolegal issues, and the interaction of medication management with other treatment strategies.
- Detailed discussion of the uses of oral, injectable and topical medications in pain management
- In-depth analysis of the top 60 medications prescribed for orofacial pain
- Comprehensive coverage of drug types, pharmacolegal issues, and the interaction of medication management with other treatment strategies
Table of Contents
- Chronic pain diseases that occur in the orofacial region.
- Top 25 most prescribed medications used in an OFP Treatment Center and how to compare medications for efficacy (include NNT and NNH).
- Metabolism of medications including liver enzymes & genetics including DDI’s, ADR’s, Cytochrome P450 table and pharmacogentics issues in OFP.
- Pharmacolegal Issues (DEA/DOJ/Off Label use and Schedule II medications tracking).
- Opioids short/long-term use and current approaches for non-malignant chronic orofacial pain.
- NSAID, Steroids and DMARDs.
- OTC agents, Oral rinses and Topical agents used for pain.
- Anti-convulsants agents and pain.
- Anti-spasmotic agents.
- Short term anxiolytic agents used in pain medicine.
- Injectable agents for pain (including Botox).
- Chronic HA medications.
- BMS treatment.
- Acute Chemo-Radiation Therapy Mucositis Prevention and Management.
- Chronic Oral Mucositis, GVHD, Ulcerative Mucosal Pain and Bleeding associated with vesculobullous lesions.
- Psychopharmacology and Pain.
- Anti-Bacterial agents and their use in pain.
- Medications as Diagnostic Tests.
- Controversial pharmacologic therapies for OFP will be reviewed
Glenn T. Clark, DDS, MS is Director of the Orofacial Pain and Oral Medicine Center at the University of Southern California Herman Ostrow School of Dentistry.
Raymond A. Dionne, DDS, PhD is Scientific Director of the Division of Intramural Research at the National Institute of Nursing Research in Washington, DC.